GST : 27AEUPJ3828B1ZE

Call us now

08045475302

Send Inquiry

Request To Call Back

HEPCINAT LP

Get a Price/Quote

MOQ : 10 Bottles

HEPCINAT LP Specification

Origin of Medicine
India

Life Span
24 Months

Pacakaging (Quantity Per Box)
28 tablets per box

Salt Composition
Ledipasvir and Sofosbuvir

Indication
Treatment of chronic Hepatitis C genotype 1 infection

Brand Name
HEPCINAT LP

Packaging Type
Box

Dosage Form
Tablet

Drug Type
Allopathic

Ingredients
Ledipasvir 90mg and Sofosbuvir 400mg

Physical Form
Tablets

Function
Antiviral (Anti Hepatitis C Virus)

Recommended For
Chronic Hepatitis C infection

Dosage
As directed by physician

Dosage Guidelines
Take orally, one tablet daily or as prescribed

Suitable For
Adults

Quantity
28 tablets

Storage Instructions
Store below 30C, protect from moisture

Prescription Required
Yes

Drug Warning
For sale in India only, not for export

Contraindications
Severe renal impairment, hypersensitivity to ingredients

Colour
Yellow

Administration Route
Oral

Side Effects
Fatigue, headache, nausea, insomnia

Therapeutic Class
Antiviral agents

Mfg Lic No.
as per packaging

Approval
DCGI-approved

Container Type
HDPE Bottle

HEPCINAT LP Trade Information

Minimum Order Quantity
10 Bottles

Payment Terms
Cash Advance (CA)

Supply Ability
5000 Bottles Per Month

Delivery Time
5-7 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

About HEPCINAT LP

HEPCINAT LP is a top-tier, DCGI-approved antiviral tablet, acclaimed for effectively treating chronic Hepatitis C (genotype 1) in adults. Combining Ledipasvir (90mg) and Sofosbuvir (400mg) in a convenient oral form, its competitive pricing offers an inestimable bargain for patients needing advanced care. Each HDPE bottle contains 28 yellow tablets, ensuring proper dosage and storage. With a life span of 24 months, this best-in-class medication is for Indian sale only and must be administered as prescribed by a qualified physician.

Diverse Applications of HEPCINAT LP

HEPCINAT LP is recommended primarily for adults with chronic Hepatitis C infection, especially genotype 1. It is commonly administered orally once daily under medical supervision. Due to its excellent antiviral properties, it is a preferred choice in hospitals, specialty clinics, and by healthcare providers experienced in hepatitis management. Its application also extends to outpatient therapy, ensuring flexibility in treatment. Usage requires strict adherence to physician guidance for safety and optimal therapeutic outcomes.

Certifications, Secure Payment, and Sample Policy

HEPCINAT LP is DCGI-approved, ensuring it meets stringent quality standards. Sale price rates are competitive, providing unparalleled value. Payment terms accommodate secure transactions, and we utilize secure shipping for all orders within India. While sample policies may vary, HEPCINAT LP maintains its acclaimed status among exporters, suppliers, and traders. All purchases and arrangements strictly comply with regulatory requirements and are offered only at approved rates for domestic sale.

FAQ's of HEPCINAT LP:

Q: How should HEPCINAT LP be administered?

A: HEPCINAT LP should be taken orally, one tablet daily, or as directed by your physician. Always follow the prescribed dosage and instructions.

Q: What are the main applications of HEPCINAT LP?

A: HEPCINAT LP is primarily used for the treatment of chronic Hepatitis C genotype 1 infections in adults. It is suitable for both hospital and outpatient settings.

Q: When is HEPCINAT LP contraindicated?

A: HEPCINAT LP is contraindicated in cases of severe renal impairment and for individuals with known hypersensitivity to any of its ingredients.

Q: Where can HEPCINAT LP be purchased?

A: HEPCINAT LP is available exclusively for sale in India through certified suppliers, exporters, and authorized healthcare providers. It is not for export.

Q: What are the potential side effects of HEPCINAT LP?

A: Common side effects include fatigue, headache, nausea, and insomnia. If you experience severe or unusual reactions, contact your healthcare professional immediately.